BR9814883A - Formulação anestésica - Google Patents

Formulação anestésica

Info

Publication number
BR9814883A
BR9814883A BR9814883-4A BR9814883A BR9814883A BR 9814883 A BR9814883 A BR 9814883A BR 9814883 A BR9814883 A BR 9814883A BR 9814883 A BR9814883 A BR 9814883A
Authority
BR
Brazil
Prior art keywords
saccharide
anesthetic
amount
anesthetic formulation
anesthetic agent
Prior art date
Application number
BR9814883-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Stephen Brown
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9724506.2A external-priority patent/GB9724506D0/en
Priority claimed from GBGB9818109.2A external-priority patent/GB9818109D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of BR9814883A publication Critical patent/BR9814883A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
BR9814883-4A 1997-11-19 1998-11-19 Formulação anestésica BR9814883A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9724506.2A GB9724506D0 (en) 1997-11-19 1997-11-19 Levobupivacaine and its use
GBGB9818109.2A GB9818109D0 (en) 1998-08-19 1998-08-19 Anaesthetic Formulation
PCT/GB1998/003479 WO1999025349A1 (en) 1997-11-19 1998-11-19 Anaesthetic formulation

Publications (1)

Publication Number Publication Date
BR9814883A true BR9814883A (pt) 2000-10-03

Family

ID=26312628

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814883-4A BR9814883A (pt) 1997-11-19 1998-11-19 Formulação anestésica

Country Status (17)

Country Link
US (1) US5932597A (enExample)
EP (1) EP1032390B1 (enExample)
JP (1) JP2001522888A (enExample)
KR (1) KR100695588B1 (enExample)
CN (1) CN1131033C (enExample)
AT (1) ATE253913T1 (enExample)
AU (1) AU740914B2 (enExample)
BR (1) BR9814883A (enExample)
CA (1) CA2308495C (enExample)
DE (1) DE69819770T2 (enExample)
DK (1) DK1032390T3 (enExample)
ES (1) ES2209217T3 (enExample)
HU (1) HU228143B1 (enExample)
IL (1) IL135922A0 (enExample)
NO (1) NO328684B1 (enExample)
PT (1) PT1032390E (enExample)
WO (1) WO1999025349A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824161D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Drug formulation
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
SI1575569T1 (sl) 2002-12-13 2010-12-31 Durect Corp Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
SI2767292T1 (sl) 2004-09-17 2017-01-31 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
EP2117521B1 (en) 2006-11-03 2012-06-27 Durect Corporation Transdermal delivery systems comprising bupivacaine
EP2067471B1 (en) * 2007-12-06 2018-02-14 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
EP3331508B1 (en) * 2015-07-13 2024-08-14 Neon Laboratories Ltd. Hyperbaric solution injection of levobupivacaine hydrochloride comprising levobupivacaine hydrochloride
JP7258561B2 (ja) 2016-07-06 2023-04-17 オリエント ファーマ シーオー．，エルティーディー． 薬物組成物、バリヤー層及び薬物層を有している経口投与形態
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
KR20230145053A (ko) 2021-01-12 2023-10-17 듀렉트 코퍼레이션 지속 방출 약물 전달 시스템 및 관련 방법
WO2025175174A1 (en) * 2024-02-14 2025-08-21 The Children's Medical Center Corporation 2'-6'-pipecoloxylidide as a sensory-selective anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802564D0 (sv) * 1988-07-08 1988-07-08 Astra Ab New synergistic preparations and a new method of alleviation of pain
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
EP0727210B1 (en) * 1993-10-13 2001-12-19 Darwin Discovery Limited Analgesic agent and its use

Also Published As

Publication number Publication date
CA2308495C (en) 2009-01-06
AU1168499A (en) 1999-06-07
HUP0004665A2 (hu) 2001-04-28
WO1999025349A1 (en) 1999-05-27
CA2308495A1 (en) 1999-05-27
NO20002545L (no) 2000-05-18
KR20010032241A (ko) 2001-04-16
EP1032390B1 (en) 2003-11-12
AU740914B2 (en) 2001-11-15
JP2001522888A (ja) 2001-11-20
ATE253913T1 (de) 2003-11-15
DK1032390T3 (da) 2004-03-15
DE69819770T2 (de) 2004-09-23
HK1026848A1 (en) 2000-12-29
DE69819770D1 (de) 2003-12-18
NO328684B1 (no) 2010-04-26
CN1279607A (zh) 2001-01-10
NO20002545D0 (no) 2000-05-18
PT1032390E (pt) 2004-04-30
KR100695588B1 (ko) 2007-03-14
EP1032390A1 (en) 2000-09-06
HUP0004665A3 (en) 2004-05-28
HU228143B1 (en) 2012-12-28
US5932597A (en) 1999-08-03
IL135922A0 (en) 2001-05-20
CN1131033C (zh) 2003-12-17
ES2209217T3 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
BR9814883A (pt) Formulação anestésica
BR0013122A (pt) Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
BR0214184A (pt) Composições que contêm óleos que possuem gravidade especìfica mais alta que a gravidade especìfica da água
BRPI0406905B8 (pt) composição de distribuição tópica em um recipiente pressurizado
MA26916A1 (fr) Procedes et compositions pour le traitement du flavivirius et de pestivirus
BR0013704A (pt) Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares
BRPI9507227B8 (pt) formulação farmacêutica para administração subcutânea, intramuscular ou intradérmica
BR0209992A (pt) Inibidor de pde4 e um agente anticolinérgico em combinação para o tratamento de doenças obstrutivas das vias respiratórias
BR9810520A (pt) Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial
BR9914419A (pt) Terapia para melhoria da percepção
JP2001522888A5 (enExample)
EA200001010A1 (ru) Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии
Bacsik et al. Toxic systemic reactions of bupivacaine and etidocaine
BRPI0414305A (pt) sistema de liberação de drogas por via oral
BR0208939A (pt) Método e agente para tratamento oftálmikco tópico de doenças inflamatórias oculares
DK0615441T3 (da) Ibuprofenholdigt lægemiddel til akut brug og dets anvendelse
ECSP045349A (es) Formuilaciones liquidas de baja dosis de entecavir y uso
ES2173124T3 (es) Composicion de dermatano sulfato utilizado como antitrombotico.
PT666739E (pt) Solucao intravenosa que diminui a perda de proteina no corpo.
ATE350024T1 (de) Flüssige zubereitung enthaltend tobramycin
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
BR9811843A (pt) Sistema de agente de consevação para produtos de tratamento corporal
ATE348621T1 (de) Flüssige darreichungsformen oxazaphosphorinhaltiger pharmazeutischer produkte
KR960013383A (ko) 항혈전성 및 피브린용해성 치료제와 조합하여 사용되는 치료제로서의 폰 빌레브란트 인자(vWF)-함유 농축물의 용도

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/445, A61K 47/02, A61K 47/26, A61K 9/08, A91P 23/00

Ipc: A61K 31/445 (2007.01), A61K 47/02 (2007.01), A61K

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA (ARTIGO 8O E 13 DA LPI).